|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1660 EUR | -1.19% |
|
-10.75% | +24.81% |
| 06-16 | IntegraGen Enters Receivership Proceedings |  |
| 05-28 | IntegraGen to file for court-ordered receivership | |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.27M | - | - | - | - | - |
| 3.98B | - | ||||
| 3.8B | |||||
| 2.87B | - | ||||
| 2.42B | - | - | |||
| 2.27B | - | - | - | - | - |
- Stock Market
- Stocks
- ALINT Stock
- Charts IntegraGen
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
